Esophageal surgical Apgar score (eSAS): A predictor for postoperative morbidity in patients undergoing neoadjuvant therapy and esophagectomy

Abstract

AbstractBackgroundThe surgical Apgar score (SAS) quantifying three intraoperative indexes has been confirmed to be significantly associated with postoperative morbidity and prognosis in many surgical specialties. However, there are great limitations in its application for esophageal cancer (EC). This study aimed to assess the predictive capability of esophagectomy SAS (eSAS) in determining postoperative morbidity and overall survival (OS) in EC patients who had undergone neoadjuvant therapy.MethodsA retrospective evaluation was conducted on a cohort of 221 patients in which surgery‐ and tumor‐related data were extracted and analyzed. Major morbidity was defined as complications meeting the criteria of Clavien‐Dindo classification III or higher during hospitalization. Univariate and multivariate analyses were performed to identify potential risk factors for major morbidity. Kaplan–Meier analysis was utilized to calculate the OS and relapse‐free survival (RFS).ResultsThe results exhibited that eSAS demonstrated potential predictive value for postoperative morbidity with an optimal cutoff value of 6. The eSAS and diabetes mellitus were two independent risk factors for the major morbidity; however, no correlation between the eSAS and the OS or RFS was detected.ConclusionThe eSAS could be used as a predictor of major morbidity, while it was not correlated with OS and RFS.